Dr Lynn P Gehrmann, DO | |
2251 N Shore Dr, Rhinelander, WI 54501-6710 | |
(715) 361-2100 | |
Not Available |
Full Name | Dr Lynn P Gehrmann |
---|---|
Gender | Female |
Speciality | Emergency Medicine |
Experience | 15 Years |
Location | 2251 N Shore Dr, Rhinelander, Wisconsin |
Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1265663413 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207P00000X | Emergency Medicine | 125.055956 (Illinois) | Secondary |
207P00000X | Emergency Medicine | 56856-21 (Wisconsin) | Primary |
Facility Name | Location | Facility Type |
---|---|---|
Ascension St Marys Hospital | Rhinelander, WI | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Aspirus Rhinelander And Tomahawk Hospitals And Clinics Inc | 9335059856 | 309 |
News Archive
Allergan plc, a leading global pharmaceutical company, and KYTHERA Biopharmaceuticals, Inc., a biopharmaceutical company focused on the discovery, development and commercialization of novel prescription products for the aesthetic medicine market, today announced that they have entered into a definitive agreement under which Allergan has agreed to acquire KYTHERA in a cash and equity transaction valued at $75 per KYTHERA share, or approximately $2.1 billion.
Cardinal Health and Patient Safety Technologies today announced that they have entered into a five-year exclusive distribution agreement to co-market the SurgiCount Safety-Sponge(TM) System, which helps prevent retention of sponges and towels unintentionally left in patients during surgical procedures.
The U.S. Food and Drug Administration today approved Osphena (ospemifene) to treat women experiencing moderate to severe dyspareunia (pain during sexual intercourse), a symptom of vulvar and vaginal atrophy due to menopause.
The U.N. Food and Agriculture Organisation (FAO) said Thursday it would help 10 countries in Central Asia and the Caucasus to preserve 25 million hectares of cultivated farmland from a "locust crisis" that is threatening food security for 20 million people, Agence France-Presse reports.
Clinical Network Services (CNS) an integrated product development company based in Australia and New Zealand providing broad services in the planning, implementation and delivery of preclinical, Phase 1 and 2 trials, today announced that it has launched a new office near London headed by Paul Cronin who joins as UK Director and Director, Business Development.
› Verified 4 days ago
Entity Name | Aspirus Rhinelander & Tomahawk Hospitals & Clinics Inc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1144991340 PECOS PAC ID: 9335059856 Enrollment ID: O20031126000706 |
News Archive
Allergan plc, a leading global pharmaceutical company, and KYTHERA Biopharmaceuticals, Inc., a biopharmaceutical company focused on the discovery, development and commercialization of novel prescription products for the aesthetic medicine market, today announced that they have entered into a definitive agreement under which Allergan has agreed to acquire KYTHERA in a cash and equity transaction valued at $75 per KYTHERA share, or approximately $2.1 billion.
Cardinal Health and Patient Safety Technologies today announced that they have entered into a five-year exclusive distribution agreement to co-market the SurgiCount Safety-Sponge(TM) System, which helps prevent retention of sponges and towels unintentionally left in patients during surgical procedures.
The U.S. Food and Drug Administration today approved Osphena (ospemifene) to treat women experiencing moderate to severe dyspareunia (pain during sexual intercourse), a symptom of vulvar and vaginal atrophy due to menopause.
The U.N. Food and Agriculture Organisation (FAO) said Thursday it would help 10 countries in Central Asia and the Caucasus to preserve 25 million hectares of cultivated farmland from a "locust crisis" that is threatening food security for 20 million people, Agence France-Presse reports.
Clinical Network Services (CNS) an integrated product development company based in Australia and New Zealand providing broad services in the planning, implementation and delivery of preclinical, Phase 1 and 2 trials, today announced that it has launched a new office near London headed by Paul Cronin who joins as UK Director and Director, Business Development.
› Verified 4 days ago
Mailing Address | Practice Location Address |
---|---|
Dr Lynn P Gehrmann, DO 2251 N Shore Dr, Rhinelander, WI 54501-6710 Ph: (715) 361-2100 | Dr Lynn P Gehrmann, DO 2251 N Shore Dr, Rhinelander, WI 54501-6710 Ph: (715) 361-2100 |
News Archive
Allergan plc, a leading global pharmaceutical company, and KYTHERA Biopharmaceuticals, Inc., a biopharmaceutical company focused on the discovery, development and commercialization of novel prescription products for the aesthetic medicine market, today announced that they have entered into a definitive agreement under which Allergan has agreed to acquire KYTHERA in a cash and equity transaction valued at $75 per KYTHERA share, or approximately $2.1 billion.
Cardinal Health and Patient Safety Technologies today announced that they have entered into a five-year exclusive distribution agreement to co-market the SurgiCount Safety-Sponge(TM) System, which helps prevent retention of sponges and towels unintentionally left in patients during surgical procedures.
The U.S. Food and Drug Administration today approved Osphena (ospemifene) to treat women experiencing moderate to severe dyspareunia (pain during sexual intercourse), a symptom of vulvar and vaginal atrophy due to menopause.
The U.N. Food and Agriculture Organisation (FAO) said Thursday it would help 10 countries in Central Asia and the Caucasus to preserve 25 million hectares of cultivated farmland from a "locust crisis" that is threatening food security for 20 million people, Agence France-Presse reports.
Clinical Network Services (CNS) an integrated product development company based in Australia and New Zealand providing broad services in the planning, implementation and delivery of preclinical, Phase 1 and 2 trials, today announced that it has launched a new office near London headed by Paul Cronin who joins as UK Director and Director, Business Development.
› Verified 4 days ago
James V Grebner, MD Emergency Medicine Medicare: Not Enrolled in Medicare Practice Location: 2251 N Shore Dr, Rhinelander, WI 54501 Phone: 715-361-2000 Fax: 715-361-2877 | |
Richard Mayrer, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 2251 N Shore Dr, Rhinelander, WI 54501 Phone: 715-361-2000 Fax: 715-361-2877 | |
Richard F Mickevicius, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 2251 N Shore Dr, Rhinelander, WI 54501 Phone: 715-361-2000 Fax: 715-361-2877 | |
Peter J Zenti, MD Emergency Medicine Medicare: Not Enrolled in Medicare Practice Location: 2251 N Shore Dr, Rhinelander, WI 54501 Phone: 715-361-2000 Fax: 715-361-2877 | |
Larry A Hooper, MD Emergency Medicine Medicare: Not Enrolled in Medicare Practice Location: 2251 N Shore Dr, Rhinelander, WI 54501 Phone: 715-361-2000 Fax: 715-361-2877 | |
Scott L Marsan, MD Emergency Medicine Medicare: Medicare Enrolled Practice Location: 2251 N Shore Dr, Rhinelander, WI 54501 Phone: 715-361-2000 Fax: 715-361-2877 |